PainReform
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PainReform and other ETFs, options, and stocks.About PRFX
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia.
CEOEhud Geller
CEOEhud Geller
Employees6
Employees6
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2007
Founded2007
Employees6
Employees6
PRFX Key Statistics
Market cap3.21M
Market cap3.21M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.49M
Average volume2.49M
High today$1.55
High today$1.55
Low today$0.79
Low today$0.79
Open price$0.84
Open price$0.84
Volume22.96M
Volume22.96M
52 Week high$6.65
52 Week high$6.65
52 Week low$0.611
52 Week low$0.611
Stock Snapshot
PainReform(PRFX) stock is priced at $1.05, giving the company a market capitalization of 3.21M.
On 2026-01-16, PainReform(PRFX) stock moved within a range of $0.79 to $1.55. With shares now at $1.05, the stock is trading +32.9% above its intraday low and -32.3% below the session's peak.
Trading activity shows a volume of 22.96M, compared to an average daily volume of 2.49M.
Over the past 52 weeks, PainReform(PRFX) stock has traded between a high of $6.65 and a low of $0.61.
Over the past 52 weeks, PainReform(PRFX) stock has traded between a high of $6.65 and a low of $0.61.
People also own
Based on the portfolios of people who own PRFX. This list is generated using Robinhood data, and it’s not a recommendation.